Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe.


Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
27 03 2019
Historique:
entrez: 29 3 2019
pubmed: 29 3 2019
medline: 21 5 2019
Statut: epublish

Résumé

Antibodies to

Identifiants

pubmed: 30918058
pii: 4/2/e00061-19
doi: 10.1128/mSphereDirect.00061-19
pmc: PMC6437277
pii:
doi:

Substances chimiques

Antibodies, Protozoan 0
Antigens, Protozoan 0
Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI089680
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Kobayashi et al.

Références

Am J Trop Med Hyg. 2019 Feb;100(2):280-286
pubmed: 30526744
Acta Trop. 2012 Mar;121(3):202-6
pubmed: 21756864
Proteomics. 2018 Jan;18(2):
pubmed: 29266845
Infect Immun. 2005 Apr;73(4):2109-15
pubmed: 15784552
Parasit Vectors. 2017 Apr 26;10(1):204
pubmed: 28441959
Mol Cell Proteomics. 2011 Sep;10(9):M111.007948
pubmed: 21628511
J Immunol. 2013 Jul 15;191(2):795-809
pubmed: 23776179
Infect Immun. 2015 Feb;83(2):646-60
pubmed: 25422270
PLoS One. 2012;7(1):e29550
pubmed: 22238621
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6958-63
pubmed: 20351286
Proteomics Clin Appl. 2011 Dec;5(11-12):613-23
pubmed: 21956928
Trends Parasitol. 2007 Dec;23(12):575-82
pubmed: 17988945
J Biol Chem. 2001 Jun 8;276(23):19937-44
pubmed: 11259426
Infect Immun. 2013 Mar;81(3):789-800
pubmed: 23275094
Am J Trop Med Hyg. 2015 Sep;93(3 Suppl):16-27
pubmed: 26259938
Malar J. 2013 Jul 01;12:223
pubmed: 23815862
Infect Immun. 2013 Oct;81(10):3709-20
pubmed: 23897618
Malar J. 2016 Apr 14;15:213
pubmed: 27075879
PLoS Med. 2016 Apr 12;13(4):e1001993
pubmed: 27071072
Parasit Vectors. 2016 Sep 21;9(1):510
pubmed: 27655231
Malar J. 2016 Jun 22;15:333
pubmed: 27333893
Malar J. 2012 Dec 31;11:438
pubmed: 23276228
Malar J. 2015 Jan 21;14:12
pubmed: 25927429
J Infect Dis. 2015 Nov 1;212(9):1429-38
pubmed: 25883384
Am J Trop Med Hyg. 2018 May;98(5):1382-1388
pubmed: 29557330
Clin Infect Dis. 2017 Mar 1;64(5):645-653
pubmed: 28362910
Proteomics. 2008 Nov;8(22):4680-94
pubmed: 18937256
Sci Rep. 2018 Apr 19;8(1):6281
pubmed: 29674705
Am J Trop Med Hyg. 2015 Sep;93(3 Suppl):5-15
pubmed: 26259946
Asian Pac J Trop Biomed. 2013 Feb;3(2):89-94
pubmed: 23593585
Malar J. 2009 Dec 02;8:274
pubmed: 19954532
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4438-47
pubmed: 26216993
Open Forum Infect Dis. 2015 Aug 26;2(3):ofv118
pubmed: 26361633
Malar J. 2015 Oct 22;14:416
pubmed: 26492873
Malar J. 2015 Jan 28;14:25
pubmed: 25888818
Am J Trop Med Hyg. 2016 Jun 1;94(6):1251-1258
pubmed: 27022156
Am J Trop Med Hyg. 2012 Sep;87(3):460-9
pubmed: 22826492
Malar J. 2017 Jan 26;16(1):48
pubmed: 28126001
Malar J. 2016 Jun 04;15:307
pubmed: 27259286
Mol Cell Proteomics. 2011 Jul;10(7):M110.006916
pubmed: 21512035
Vaccine. 2015 Dec 22;33(52):7496-505
pubmed: 26428458
Am J Trop Med Hyg. 2007 Aug;77(2):316-23
pubmed: 17690405
PLoS One. 2013 Dec 02;8(12):e82246
pubmed: 24312649
PLoS Negl Trop Dis. 2017 Jan 24;11(1):e0005323
pubmed: 28118367
Malar J. 2014 Apr 23;13:153
pubmed: 24755108
PLoS One. 2015 Mar 13;10(3):e0118901
pubmed: 25768015
Clin Infect Dis. 2010 Oct 15;51(8):e50-60
pubmed: 20843207
PLoS One. 2016 Mar 28;11(3):e0151971
pubmed: 27018893
Malar J. 2015 Feb 25;14:95
pubmed: 25849211
Sci Rep. 2013 Dec 19;3:3549
pubmed: 24351974
Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5108-13
pubmed: 15792998
Proteomics. 2016 Apr;16(8):1271-9
pubmed: 26842269
PLoS One. 2013 Sep 10;8(9):e72504
pubmed: 24039774
PLoS Negl Trop Dis. 2017 May 19;11(5):e0005616
pubmed: 28542223

Auteurs

Tamaki Kobayashi (T)

Johns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Aarti Jain (A)

Vaccine Research & Development Center, Department of Physiology & Biophysics, School of Medicine, University of California, Irvine, Irvine, California, USA.

Li Liang (L)

Vaccine Research & Development Center, Department of Physiology & Biophysics, School of Medicine, University of California, Irvine, Irvine, California, USA.

Joshua M Obiero (JM)

Vaccine Research & Development Center, Department of Physiology & Biophysics, School of Medicine, University of California, Irvine, Irvine, California, USA.

Harry Hamapumbu (H)

Macha Research Trust, Choma, Zambia.

Jennifer C Stevenson (JC)

Johns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Macha Research Trust, Choma, Zambia.

Philip E Thuma (PE)

Johns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Macha Research Trust, Choma, Zambia.

James Lupiya (J)

Tropical Diseases Research Centre, Ndola, Zambia.

Mike Chaponda (M)

Tropical Diseases Research Centre, Ndola, Zambia.

Modest Mulenga (M)

Tropical Diseases Research Centre, Ndola, Zambia.

Edmore Mamini (E)

Biomedical Research and Training Institute, Harare, Zimbabwe.

Sungano Mharakurwa (S)

Biomedical Research and Training Institute, Harare, Zimbabwe.

Lovemore Gwanzura (L)

Biomedical Research and Training Institute, Harare, Zimbabwe.

Shungu Munyati (S)

Biomedical Research and Training Institute, Harare, Zimbabwe.

Susan Mutambu (S)

National Institute of Health Research, Harare, Zimbabwe.

Philip Felgner (P)

Vaccine Research & Development Center, Department of Physiology & Biophysics, School of Medicine, University of California, Irvine, Irvine, California, USA.

D Huw Davies (DH)

Vaccine Research & Development Center, Department of Physiology & Biophysics, School of Medicine, University of California, Irvine, Irvine, California, USA ddavies@uci.edu.

William J Moss (WJ)

Johns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH